Literature DB >> 6783121

Distribution of conduritol B epoxide in the animal model for Gaucher's disease (Gaucher mouse).

M C Stephens, A Bernatsky, H Singh, J N Kanfer, G Legler.   

Abstract

The time course of the distribution of the beta-glucosidase inhibitor [3H]conduritol B epoxide was determined in various organs of mice, which had received a single interperitoneal dose of the inhibitor. The epoxide is rapidly distributed over all tissues except brain where its concentration is only one-tenth of the average. This is considered an indication that the epoxide can pass the blood/brain barrier only with difficulty. A 4-fold enrichment is seen in the kidney. The inhibitor is excreted with a half-life of about 7 h; it is not metabolized. A parallel determination of beta-glucosidase activity in the tissues showed greater than 90% inhibition within 1 and 2 h and a beginning recovery between 4 and 12 h. The only exception was brain, where no effects could be seen after 1 h and where a subsequent decrease to 37% of normal was observed after 12 h.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6783121     DOI: 10.1016/0304-4165(81)90276-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  2 in total

1.  Glucosylceramide and the level of the glucosidase-stimulating proteins.

Authors:  S C Datta; N S Radin
Journal:  Lipids       Date:  1986-11       Impact factor: 1.880

2.  Innate immune response in neuronopathic forms of Gaucher disease confers resistance against viral-induced encephalitis.

Authors:  Sharon Melamed; Roy Avraham; Deborah E Rothbard; Noam Erez; Tomer Israely; Ziv Klausner; Anthony H Futerman; Nir Paran; Einat B Vitner
Journal:  Acta Neuropathol Commun       Date:  2020-08-24       Impact factor: 7.801

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.